Improved systolic function of rat cardiocytes during heart failure by overexpression of SERCA2a

被引:0
|
作者
Gong, H. -B. [1 ]
Wang, L. [1 ]
Lv, Q. [1 ]
Wang, J. [1 ]
机构
[1] Xuzhou Cent Hosp, Dept Cardiol, Xuzhou Cardiovasc Dis Inst, Xuzhou, Jiangsu, Peoples R China
关键词
SERCA2a; Overexpression; Heart failure; Arrhythmia; Cardiocyte function; GENE; MYOCYTES; LEAK;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: This study shows that overexpression of SERCA2a can improve the systolic function and reduce the occurrence of arrhythmias in cardiocytes isolated from the heart of a rat model of heart failure. MATERIALS AND METHODS: An animal model of rats experiencing heart failure was established by a surgical procedure producing abdominal aortic coarctation. Cardiocytes from sacrificed rats were isolated by a collagenase digestion method. The SERCA2a adenovirus vector was transfected into the cells after 48h of culture. Overexpression of SERCA2a in cardiocytes was verified by Western Blot. Measurements were taken using a single cell dynamic edge detection system to evaluate the effects on the myocardiocyte function and calcium homeostasis. RESULTS: Cardiocytes overexpressing SERCA2a displayed a stronger systolic function and lower occurrence rate of abnormal systolic rhythm than mock-transfected cardiocytes. The contraction rhythm abnormality rate percentage was 5.270 +/- 1.566% vs. 3.955 +/- 1.684% (p < 0.01). The time at which they reached the maximum contraction (TTP) was 0.095 +/- 0.009s vs. 0.114 +/- 0.008s (p < 0.01). The time at which they reached 50% of the diastolic amplitude (R50) was 0.039 +/- 0.008s vs. 0.057 +/- 0.010s (p < 0.01). Finally, the occurrence rate of abnormal systolic rhythm during maximal contraction was 58% vs. 81% (p < 0.01). These results show that all data were significantly improved in the SERCA2a overexpressing group, and that parameters achieved were similar to those in the sham-operated nonheart failure group. CONCLUSIONS: The overexpression of SERCA2a in cardiocytes during heart failure significantly improves cell function and arrhythmia occurrence.
引用
收藏
页码:1590 / 1596
页数:7
相关论文
共 50 条
  • [1] SERCA2a gene transfer improves diastolic function in ischemic heart failure
    Ishikawa, K.
    Tilemann, L.
    Ladage, D.
    Fish, K.
    Kawase, Y.
    Hajjar, R.
    EUROPEAN HEART JOURNAL, 2011, 32 : 791 - 791
  • [2] Weighing in on Heart Failure: The Role of SERCA2a SUMOylation
    Schwartz, Robert J.
    Yeh, Edward T. H.
    CIRCULATION RESEARCH, 2012, 110 (02) : 198 - 199
  • [3] SERCA2a: a prime target for modulation of cardiac contractility during heart failure
    Park, Woo Jin
    Oh, Jae Gyun
    BMB REPORTS, 2013, 46 (05) : 237 - 243
  • [4] Proteomic Analysis of SERCA2a in Setting of Heart Failure
    Kho, Changwon
    Lee, Ahyoung
    Teixeira, Avelino
    Hajjar, Roger J.
    CIRCULATION RESEARCH, 2008, 103 (05) : E36 - E36
  • [5] SERCA2a in heart failure: Role and therapeutic prospects
    Gianni, D
    Chan, J
    Gwathmey, JK
    del Monte, F
    Hajjar, RJ
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2005, 37 (06) : 375 - 380
  • [6] SERCA2a in Heart Failure: Role and Therapeutic Prospects
    Davide Gianni
    Joachim Chan
    Judith K. Gwathmey
    Federica del Monte
    Roger J. Hajjar
    Journal of Bioenergetics and Biomembranes, 2005, 37 : 375 - 380
  • [7] Heterogeneous SERCA2a transfection reduces ventricular arrhythmias in the rat model of heart failure
    Lyon, Alexander
    Sepehripour, Amir
    Dubb, Sukhpreet
    Macleod, Ken
    Poole-Wilson, Philip
    Peters, Nicholas
    Harding, Sian
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (04) : 714 - 715
  • [8] Cardiac SERCA2A/B: Therapeutic targets for heart failure
    Shareef, Mohammad Abrar
    Anwer, Lucman A.
    Poizat, Coralie
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 724 : 1 - 8
  • [9] "Sorting" SERCA2a: A novel therapeutic strategy in heart failure?
    Chelu, Mihail G.
    Li, Na
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 272 : 306 - 307
  • [10] SERCA2a gene therapy for heart failure: Ready for primetime?
    Periasamy, Muthu
    Kalyanasundaram, Anuradha
    MOLECULAR THERAPY, 2008, 16 (06) : 1002 - 1004